A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples